BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23378237)

  • 1. Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts.
    Quan J; Elhousiny M; Johnson NW; Gao J
    Clin Exp Metastasis; 2013 Jun; 30(5):659-70. PubMed ID: 23378237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
    Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
    Qiao B; Johnson NW; Gao J
    Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-mediated Pathway in Oral Squamous Cell Carcinoma.
    Kim SR; Lee EY; Kim DJ; Kim HJ; Park HR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32050534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
    Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
    Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 promotes cells invasion and migration by inducing epithelial mesenchymal transformation in oral squamous cell carcinoma.
    Bu JQ; Chen F
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2137-2144. PubMed ID: 28537671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.
    Lv S; Luo T; Yang Y; Li Y; Yang J; Xu J; Zheng J; Zeng Y
    J Cell Mol Med; 2021 Jul; 25(14):6760-6772. PubMed ID: 34060226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1 and IL-17A comediate the protumor phenotype of neutrophils to regulate the epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Yu T; Tang Q; Chen X; Fan W; Zhou Z; Huang W; Liang F
    J Oral Pathol Med; 2021 Apr; 50(4):353-361. PubMed ID: 33164231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.
    Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M
    Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
    Yao Y; Chen R; Wang G; Zhang Y; Liu F
    Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.
    Hu L; Liu J; Li Z; Wang C; Nawshad A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):460-482.e4. PubMed ID: 27567435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of TGF-β1 on tumor transition in oral cancer cell and BMSC co-cultures.
    Böhrnsen F; Godek F; Kiesel J; Kramer FJ; Brockmeyer P; Schliephake H
    J Craniomaxillofac Surg; 2017 May; 45(5):731-740. PubMed ID: 28318921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.